Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): A stratified, biopsy-driven, multi-centre, randomised, open label, controll... by Humby, F, Durez, P, Buch, MH, Lewis, M, Rizvi, H, Rivellese, F, Nerviani, A, Giorli, G, Mahto, A, Montecucco, C, Lauwerys, B, Ng, N, Ho, P, Bombardieri, M, Romão, VC, Verschueren, P, Kelly, S, Sainaghi, PP, Gendi, N, Dasgupta, B, Cauli, A, Reynolds, P, Cañete, JD, Moots, R, Taylor, P, Edwards, CJ, Isaacs, J, Sasieni, P, Choy, E, Pitzalis, C